In addition, pitching to venture capital led to funding through the Medical Research Future Fund.

Take home message?

I have wanted to quit research regularly. The lows are really low.

But if you love research like I do, get good mentors, collaborate and look for innovative ways to get funding.

3 – Alternative funding sources

I worked hard with our consumer panel to successfully pitch our research for CIA funding from NBCF, PCFA/Movember, Cancer Council NSW, Cancer Institute NSW (including SPHERE/Sydney Cancer Partners), Ramaciotti, Tour de Cure, Charlie Teo Foundation.

2 – Collaborations

My early work on transporters wasn’t “sexy” research on its own, but was funded as part of larger PCFA/Movember collaborative programs with senior colleagues.

Recent collaborations resulted in MRFF funding as CIA and CIC in areas of research outside my cancer metabolism focus.

Considering this lack of NHMRC funding, how did I survive?

1 – Luck

Friends and colleagues focussed on the bad luck – many near miss grants within 0.2 of the cutoff (2015/17/19/22/23) were touted as “bad luck” – don’t worry, you’ll get it next year. But I had good luck in near miss grant awards.

After 11 years of rejection, I learnt not to take the scores personally – but to try and learn from them. The graph below shows my scores have improved over time. But why?

Firstly, looking at my early scores, track record was not the problem, but my scientific quality and significance were low.

Reflecting on an amazing year of Tour de Cure fundraising completing 6 events!

Ten years of the #Can4Cancer campaign has contributed ~$20M to cancer research in Aus.👏

Capped off with a $100K grant award from Tour de Cure for our #glioblastoma work!

Dedicating this work to Rohan. Vale my friend.